{"id":61068,"date":"2026-10-20T20:53:03","date_gmt":"2026-10-20T18:53:03","guid":{"rendered":"https:\/\/www.fyb.de\/oppenhoff-advises-resonant-clinical-solutions-on-the-acquisition-of-labfish\/"},"modified":"2026-10-20T20:53:33","modified_gmt":"2026-10-20T18:53:33","slug":"oppenhoff-advises-resonant-clinical-solutions-on-the-acquisition-of-labfish","status":"publish","type":"post","link":"https:\/\/www.fyb.de\/en\/oppenhoff-advises-resonant-clinical-solutions-on-the-acquisition-of-labfish\/","title":{"rendered":"Oppenhoff Advises Resonant Clinical Solutions on the Acquisition of Labfish"},"content":{"rendered":"<p>Hamburg \u2013 Oppen\u00adhoff advi\u00adsed Reso\u00adnant Clini\u00adcal Solu\u00adti\u00adons, a port\u00adfo\u00adlio company of Audax Private Equity, on its acqui\u00adsi\u00adtion of labfish rental solu\u00adti\u00adons GmbH and its affi\u00adlia\u00adted compa\u00adnies (\u201cLabfish\u201d) in the United States and the United King\u00addom. With this acqui\u00adsi\u00adtion, Reso\u00adnant is further expan\u00adding its presence in the Euro\u00adpean Equip\u00adment &amp; Ancil\u00adla\u00adries (E&amp;A) market and broa\u00adde\u00adning its range of services for complex clini\u00adcal trials.&nbsp;<\/p>\n<p>Reso\u00adnant is a global provi\u00adder of solu\u00adti\u00adons for life scien\u00adces compa\u00adnies across the clini\u00adcal supply chain and the entire life cycle of biolo\u00adgi\u00adcal samples. Among other things, the company offers services for the storage and manage\u00adment of biolo\u00adgi\u00adcal samples, as well as the provi\u00adsion of kits, devices, and supple\u00admen\u00adtary mate\u00adri\u00adals for clini\u00adcal trials. Reso\u00adnant employs more than 850 people in the U.S. and Europe and has supported over 2,500 clini\u00adcal trials to&nbsp;date.&nbsp;<\/p>\n<p><strong>Labfish<\/strong>, head\u00adquar\u00adte\u00adred in Hamburg, was foun\u00added in 2014 and supplies labo\u00adra\u00adtory and clini\u00adcal equip\u00adment. In addi\u00adtion, the company offers cali\u00adbra\u00adtion, import, and export services, as well as logi\u00adstics services for clini\u00adcal trials. Labfish supplies trial sites in more than 70 count\u00adries and opera\u00adtes one of the largest company-owned cali\u00adbra\u00adtion faci\u00adli\u00adties for clini\u00adcal trials in Europe.&nbsp;<\/p>\n<p><strong>Audax Private Equity<\/strong>, head\u00adquar\u00adte\u00adred in Boston with addi\u00adtio\u00adnal offices in San Fran\u00adcisco, New York, London, and Hong Kong, is a leading private equity firm focu\u00adsed on inves\u00adt\u00ading in mid-market compa\u00adnies in North America.<br>\nhttps:\/\/audaxprivateequity.com\/<\/p>\n<p><strong>Consul\u00adtant at Reso\u00adnant Clini\u00adcal Solu\u00adti\u00adons: Oppenhoff<\/strong><\/p>\n<p>Led by Dr. Markus Rasner, Moritz Schmitz, Laurenz Kiefer (all Private Equity), Dr. Gunnar Knorr (Tax), Dr. Wolf\u00adgang Kotzur (Finance), Anja Dombrow\u00adsky and Lisa Strieg\u00adler (both Employ\u00adment Law), Maxi\u00admi\u00adlian Broich (Compli\u00adance), Valen\u00adtino Halim and Melissa Irtel (both IT\/Data Protec\u00adtion), Julia H\u00f6yng and Anto\u00adnia van Dam (both Real Estate), Dr. Patric Mau (Intellec\u00adtual Property), as well as Chris\u00adtine Seiz and Sarah Liomin (both Commer\u00adcial), Dr. Cars\u00adten Bormann and Mareike Heesing (both Foreign Invest\u00adment), Daniel Dohrn and Konstan\u00adtin Ogil\u00advie (both anti\u00adtrust law). Holland &amp; Knight advi\u00adsed on U.S. legal matters, and Walker Morris advi\u00adsed on U.K. legal matters.&nbsp;<\/p>\n<p><strong>About Oppen\u00adhoff<\/strong><\/p>\n<p>The Oppen\u00adhoff team had previously advi\u00adsed on the German aspects of the carve-out and acqui\u00adsi\u00adtion of Avan\u00adtor Inc.\u2019s Clini\u00adcal Services divi\u00adsion. The resul\u00adting inde\u00adpen\u00addent plat\u00adform was subse\u00adquently rena\u00admed Reso\u00adnant Clini\u00adcal Solu\u00adti\u00adons. Oppen\u00adhoff regu\u00adlarly advi\u00adses on add-on acqui\u00adsi\u00adti\u00adons of plat\u00adforms in the private equity sector; most recently, among others, Schenk Tank\u00adtrans\u00adport on its acqui\u00adsi\u00adtion of Franz Fischer Spedi\u00adtion, Rensa Filtra\u00adtion on its acqui\u00adsi\u00adtion of IREMA-Filter GmbH and its U.S. subsi\u00addiary Aeolus Filter, and Stat\u00adLab Medi\u00adcal Products on its acqui\u00adsi\u00adtion of Histo\u00adserve. \u2014 www.oppenhoff.eu     <\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Hamburg \u2013 Oppen\u00adhoff advi\u00adsed Reso\u00adnant Clini\u00adcal Solu\u00adti\u00adons, a port\u00adfo\u00adlio company of Audax Private Equity, on its acqui\u00adsi\u00adtion of labfish rental solu\u00adti\u00adons GmbH and its affi\u00adlia\u00adted compa\u00adnies (\u201cLabfish\u201d) in the United States and the United King\u00addom. With this acqui\u00adsi\u00adtion, Reso\u00adnant is further expan\u00adding its presence in the Euro\u00adpean Equip\u00adment &amp; Ancil\u00adla\u00adries (E&amp;A) market and broa\u00adde\u00adning&nbsp;its&nbsp;[\u2026]<\/p>\n","protected":false},"author":2,"featured_media":61066,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"wp_typography_post_enhancements_disabled":false,"footnotes":""},"categories":[1366],"tags":[],"class_list":["post-61068","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-en"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Oppenhoff Advises Resonant Clinical Solutions on the Acquisition of Labfish - FYB Financial Yearbook<\/title>\n<meta name=\"description\" content=\"Hamburg \u2013 Oppenhoff advised Resonant Clinical Solutions, a portfolio company of Audax Private Equity, on its acquisition of labfish rental solutions GmbH and its affiliated companies in the U.S. and the U.K. With this acquisition, Resonant is further expanding its presence in the European market for equipment and ancillaries and broadening its range of services for complex clinical trials.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.fyb.de\/en\/oppenhoff-advises-resonant-clinical-solutions-on-the-acquisition-of-labfish\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Oppenhoff Advises Resonant Clinical Solutions on the Acquisition of Labfish - FYB Financial Yearbook\" \/>\n<meta property=\"og:description\" content=\"Hamburg \u2013 Oppenhoff advised Resonant Clinical Solutions, a portfolio company of Audax Private Equity, on its acquisition of labfish rental solutions GmbH and its affiliated companies in the U.S. and the U.K. With this acquisition, Resonant is further expanding its presence in the European market for equipment and ancillaries and broadening its range of services for complex clinical trials.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.fyb.de\/en\/oppenhoff-advises-resonant-clinical-solutions-on-the-acquisition-of-labfish\/\" \/>\n<meta property=\"og:site_name\" content=\"FYB Financial Yearbook\" \/>\n<meta property=\"article:published_time\" content=\"2026-10-20T18:53:03+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-10-20T18:53:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.fyb.de\/wp-content\/uploads\/2026\/10\/rasner-markus-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2048\" \/>\n\t<meta property=\"og:image:height\" content=\"1429\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Tatjana Anderer\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Tatjana Anderer\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.fyb.de\/en\/oppenhoff-advises-resonant-clinical-solutions-on-the-acquisition-of-labfish\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.fyb.de\/en\/oppenhoff-advises-resonant-clinical-solutions-on-the-acquisition-of-labfish\/\"},\"author\":{\"name\":\"Tatjana Anderer\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce\"},\"headline\":\"Oppenhoff Advises Resonant Clinical Solutions on the Acquisition of Labfish\",\"datePublished\":\"2026-10-20T18:53:03+00:00\",\"dateModified\":\"2026-10-20T18:53:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.fyb.de\/en\/oppenhoff-advises-resonant-clinical-solutions-on-the-acquisition-of-labfish\/\"},\"wordCount\":426,\"publisher\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.fyb.de\/en\/oppenhoff-advises-resonant-clinical-solutions-on-the-acquisition-of-labfish\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2026\/10\/rasner-markus-scaled.jpg\",\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.fyb.de\/en\/oppenhoff-advises-resonant-clinical-solutions-on-the-acquisition-of-labfish\/\",\"url\":\"https:\/\/www.fyb.de\/en\/oppenhoff-advises-resonant-clinical-solutions-on-the-acquisition-of-labfish\/\",\"name\":\"Oppenhoff Advises Resonant Clinical Solutions on the Acquisition of Labfish - FYB Financial Yearbook\",\"isPartOf\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.fyb.de\/en\/oppenhoff-advises-resonant-clinical-solutions-on-the-acquisition-of-labfish\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.fyb.de\/en\/oppenhoff-advises-resonant-clinical-solutions-on-the-acquisition-of-labfish\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2026\/10\/rasner-markus-scaled.jpg\",\"datePublished\":\"2026-10-20T18:53:03+00:00\",\"dateModified\":\"2026-10-20T18:53:33+00:00\",\"description\":\"Hamburg \u2013 Oppenhoff advised Resonant Clinical Solutions, a portfolio company of Audax Private Equity, on its acquisition of labfish rental solutions GmbH and its affiliated companies in the U.S. and the U.K. With this acquisition, Resonant is further expanding its presence in the European market for equipment and ancillaries and broadening its range of services for complex clinical trials.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.fyb.de\/en\/oppenhoff-advises-resonant-clinical-solutions-on-the-acquisition-of-labfish\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.fyb.de\/en\/oppenhoff-advises-resonant-clinical-solutions-on-the-acquisition-of-labfish\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.fyb.de\/en\/oppenhoff-advises-resonant-clinical-solutions-on-the-acquisition-of-labfish\/#primaryimage\",\"url\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2026\/10\/rasner-markus-scaled.jpg\",\"contentUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2026\/10\/rasner-markus-scaled.jpg\",\"width\":2048,\"height\":1429,\"caption\":\"Dr. Markus Rasner, Partner bei Oppenhoff (\u00a9 Oppenhoff)\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.fyb.de\/en\/oppenhoff-advises-resonant-clinical-solutions-on-the-acquisition-of-labfish\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.fyb.de\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Oppenhoff Advises Resonant Clinical Solutions on the Acquisition of Labfish\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.fyb.de\/en\/#website\",\"url\":\"https:\/\/www.fyb.de\/en\/\",\"name\":\"FYB Financial Yearbook\",\"description\":\"For Your Business\",\"publisher\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.fyb.de\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.fyb.de\/en\/#organization\",\"name\":\"FYB Financial Yearbook\",\"url\":\"https:\/\/www.fyb.de\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg\",\"contentUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg\",\"caption\":\"FYB Financial Yearbook\"},\"image\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce\",\"name\":\"Tatjana Anderer\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g\",\"caption\":\"Tatjana Anderer\"},\"description\":\"Gr\u00fcnderin des FYB-Verlag\",\"sameAs\":[\"http:\/\/neu.fyb.de\"],\"url\":\"https:\/\/www.fyb.de\/en\/author\/tanderer\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Oppenhoff Advises Resonant Clinical Solutions on the Acquisition of Labfish - FYB Financial Yearbook","description":"Hamburg \u2013 Oppenhoff advised Resonant Clinical Solutions, a portfolio company of Audax Private Equity, on its acquisition of labfish rental solutions GmbH and its affiliated companies in the U.S. and the U.K. With this acquisition, Resonant is further expanding its presence in the European market for equipment and ancillaries and broadening its range of services for complex clinical trials.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.fyb.de\/en\/oppenhoff-advises-resonant-clinical-solutions-on-the-acquisition-of-labfish\/","og_locale":"en_US","og_type":"article","og_title":"Oppenhoff Advises Resonant Clinical Solutions on the Acquisition of Labfish - FYB Financial Yearbook","og_description":"Hamburg \u2013 Oppenhoff advised Resonant Clinical Solutions, a portfolio company of Audax Private Equity, on its acquisition of labfish rental solutions GmbH and its affiliated companies in the U.S. and the U.K. With this acquisition, Resonant is further expanding its presence in the European market for equipment and ancillaries and broadening its range of services for complex clinical trials.","og_url":"https:\/\/www.fyb.de\/en\/oppenhoff-advises-resonant-clinical-solutions-on-the-acquisition-of-labfish\/","og_site_name":"FYB Financial Yearbook","article_published_time":"2026-10-20T18:53:03+00:00","article_modified_time":"2026-10-20T18:53:33+00:00","og_image":[{"width":2048,"height":1429,"url":"https:\/\/www.fyb.de\/wp-content\/uploads\/2026\/10\/rasner-markus-scaled.jpg","type":"image\/jpeg"}],"author":"Tatjana Anderer","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Tatjana Anderer","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.fyb.de\/en\/oppenhoff-advises-resonant-clinical-solutions-on-the-acquisition-of-labfish\/#article","isPartOf":{"@id":"https:\/\/www.fyb.de\/en\/oppenhoff-advises-resonant-clinical-solutions-on-the-acquisition-of-labfish\/"},"author":{"name":"Tatjana Anderer","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce"},"headline":"Oppenhoff Advises Resonant Clinical Solutions on the Acquisition of Labfish","datePublished":"2026-10-20T18:53:03+00:00","dateModified":"2026-10-20T18:53:33+00:00","mainEntityOfPage":{"@id":"https:\/\/www.fyb.de\/en\/oppenhoff-advises-resonant-clinical-solutions-on-the-acquisition-of-labfish\/"},"wordCount":426,"publisher":{"@id":"https:\/\/www.fyb.de\/en\/#organization"},"image":{"@id":"https:\/\/www.fyb.de\/en\/oppenhoff-advises-resonant-clinical-solutions-on-the-acquisition-of-labfish\/#primaryimage"},"thumbnailUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2026\/10\/rasner-markus-scaled.jpg","articleSection":["News"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.fyb.de\/en\/oppenhoff-advises-resonant-clinical-solutions-on-the-acquisition-of-labfish\/","url":"https:\/\/www.fyb.de\/en\/oppenhoff-advises-resonant-clinical-solutions-on-the-acquisition-of-labfish\/","name":"Oppenhoff Advises Resonant Clinical Solutions on the Acquisition of Labfish - FYB Financial Yearbook","isPartOf":{"@id":"https:\/\/www.fyb.de\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.fyb.de\/en\/oppenhoff-advises-resonant-clinical-solutions-on-the-acquisition-of-labfish\/#primaryimage"},"image":{"@id":"https:\/\/www.fyb.de\/en\/oppenhoff-advises-resonant-clinical-solutions-on-the-acquisition-of-labfish\/#primaryimage"},"thumbnailUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2026\/10\/rasner-markus-scaled.jpg","datePublished":"2026-10-20T18:53:03+00:00","dateModified":"2026-10-20T18:53:33+00:00","description":"Hamburg \u2013 Oppenhoff advised Resonant Clinical Solutions, a portfolio company of Audax Private Equity, on its acquisition of labfish rental solutions GmbH and its affiliated companies in the U.S. and the U.K. With this acquisition, Resonant is further expanding its presence in the European market for equipment and ancillaries and broadening its range of services for complex clinical trials.","breadcrumb":{"@id":"https:\/\/www.fyb.de\/en\/oppenhoff-advises-resonant-clinical-solutions-on-the-acquisition-of-labfish\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.fyb.de\/en\/oppenhoff-advises-resonant-clinical-solutions-on-the-acquisition-of-labfish\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.fyb.de\/en\/oppenhoff-advises-resonant-clinical-solutions-on-the-acquisition-of-labfish\/#primaryimage","url":"https:\/\/www.fyb.de\/wp-content\/uploads\/2026\/10\/rasner-markus-scaled.jpg","contentUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2026\/10\/rasner-markus-scaled.jpg","width":2048,"height":1429,"caption":"Dr. Markus Rasner, Partner bei Oppenhoff (\u00a9 Oppenhoff)"},{"@type":"BreadcrumbList","@id":"https:\/\/www.fyb.de\/en\/oppenhoff-advises-resonant-clinical-solutions-on-the-acquisition-of-labfish\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.fyb.de\/en\/"},{"@type":"ListItem","position":2,"name":"Oppenhoff Advises Resonant Clinical Solutions on the Acquisition of Labfish"}]},{"@type":"WebSite","@id":"https:\/\/www.fyb.de\/en\/#website","url":"https:\/\/www.fyb.de\/en\/","name":"FYB Financial Yearbook","description":"For Your Business","publisher":{"@id":"https:\/\/www.fyb.de\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.fyb.de\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.fyb.de\/en\/#organization","name":"FYB Financial Yearbook","url":"https:\/\/www.fyb.de\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg","contentUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg","caption":"FYB Financial Yearbook"},"image":{"@id":"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce","name":"Tatjana Anderer","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g","caption":"Tatjana Anderer"},"description":"Gr\u00fcnderin des FYB-Verlag","sameAs":["http:\/\/neu.fyb.de"],"url":"https:\/\/www.fyb.de\/en\/author\/tanderer\/"}]}},"_links":{"self":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/posts\/61068","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/comments?post=61068"}],"version-history":[{"count":1,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/posts\/61068\/revisions"}],"predecessor-version":[{"id":61069,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/posts\/61068\/revisions\/61069"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/media\/61066"}],"wp:attachment":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/media?parent=61068"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/categories?post=61068"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/tags?post=61068"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}